Essential Thrombocythemia Developing into Refractory Anemia and Complicated by Acute Myeloid Leukemia

8Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

We report a case of essential thrombocythemia (ET) that climaxed in acute myeloid leukemia after developing into refractory anemia. The male patient had ET that was stable for 8 years on carboquone therapy. However, at the age of 72 years he developed an acute terminal illness that was characterized by severe pancytopenia, circulating myeloblasts, extensive bone marrow infiltration by myeloblasts, and an abnormal karyotype [46, XY, t(8q-; 20q+)]. He subsequently died of severe bilateral pneumonia and heart failure. This case suggests that ET may be similar to polycythemia vera; progression to leukemia is unusual except after chemotherapy. Therefore, treatment of patients with asymptomatic ET may not be advisable. © 1992, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Yonekura, S., Nagao, T., & Arimori, S. (1992). Essential Thrombocythemia Developing into Refractory Anemia and Complicated by Acute Myeloid Leukemia. Internal Medicine, 31(10), 1224–1227. https://doi.org/10.2169/internalmedicine.31.1224

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free